Glutamate Receptors and Nociception: Implications for the Drug Treatment of Pain
The DOI matches its Crossref record; 510 of the 513 references it cites were found in a registry or an index.
Abstract
Evidence from the last several decades indicates that the excitatory amino acid glutamate plays a significant role in nociceptive processing. Glutamate and glutamate receptors are located in areas of the brain, spinal cord and periphery that are involved in pain sensation and transmission. Glutamate acts at several types of receptors, including ionotropic (directly coupled to ion channels) and metabotropic (directly coupled to intracellular second messengers). Ionotropic receptors include those selectively activated by N-methyl-D-aspartate, alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate. Metabotropic glutamate receptors are classified into 3 groups based on sequence homology, signal transduction mechanisms and receptor pharmacology. Glutamate also interacts with the opioid system, and intrathecal or systemic coadministration of glutamate receptor antagonists with opioids may enhance analgesia while reducing the development of opioid tolerance and dependence. The actions of glutamate in the brain seem to be more complex. Activation of glutamate receptors in some brain areas seems to be pronociceptive (e.g. thalamus, trigeminal nucleus), although activation of glutamate receptors in other brain areas seems to be antinociceptive (e.g. periaqueductal grey, ventrolateral medulla). Application of glutamate, or agonists selective for one of the several types of glutamate receptor, to the spinal cord or periphery induces nociceptive behaviours. Inhibition of glu…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both systems appear essential, though not independently sufficient, to induce ketamine’s AD action [81,82,83].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [81]
Citations
Cites
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J.-P. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,081
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones
Mayer, M. L., Westbrook, G. L., & Guthrie, P. B. (1984) · Nature · doi:10.1038/309261a0 · Cited by 2,893
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Woolf, C. J., & Thompson, S. W. N. (1991) · Pain · doi:10.1016/0304-3959(91)90100-c · Cited by 1,963
MacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J., & Barker, J. L. (1986) · Nature · doi:10.1038/321519a0 · Cited by 1,835
Molecular cloning and characterization of the rat NMDA receptor
Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., & Nakanishi, S. (1991) · Nature · doi:10.1038/354031a0 · Cited by 1,771 · cited 1×
“[1,12-17]NMDA receptors mediate slow excitatory postsynaptic potentials, and activation of these receptors stimulates protein kinase C (PKC) activation[18] and nitric oxide (NO) production via Ca2+/calmodulin activation of nitric oxide synthase (NOS).”
Background
Research works printed but not linked: 44
- Murphy, 1989, J Pharmacol Exp Ther, 249, 184
- Saugstad, 1994, Mol Pharmacol, 45, 367
- Miller, 1988, J Comp Neurol, 277, 28
- Catania, 1994, Mol Pharmacol, 45, 626
- Greenamyre, 1985, J Pharmacol Exp Ther, 233, 254
- Aanonsen, 1987, J Pharmacol Exp Ther, 243, 9
- Aanonsen, 1989, J Pharmacol Exp Ther, 248, 1034
- Rice, 1994, Pain, 335-, 40
- Kolhekar, 1994, Neuroscience, 63, 925, 10.1016/0306-4522(94)90560-6 · DOI
- Renno, 1998, Neurobiology (Bp), 6, 333
- Burton, 1999, Reg Anesth Pain Med, 24, 208
- Wong, 1998, Anesth Analg, 87, 605, 10.1213/00000539-199809000-00021 · doi:10.1213/00000539-199809000-00021
- Ault, 1993, J Pharmacol Exp Ther, 265, 927
- Nishiyama, 1999, Anesth Analg, 89, 143, 10.1213/00000539-199907000-00024 · doi:10.1213/00000539-199907000-00024
- Xu, 1993, J Pharmacol Exp Ther, 267, 140
- Fundytus, 1997, Soc Neurosci Abstracts, 23, 1013
- Fundytus, 2000, Prog Pain Res Manag, 16, 343
- Zahn, 1998, Anesth Analg, 87, 1354, 10.1213/00000539-199812000-00026 · doi:10.1213/00000539-199812000-00026
- Fundytus, 1999, Pain Res Manag, 4, 34
- Mayer, 1995, NIDA Res Monogr, 147, 269
- Bleakman, 1992, Mol Pharmacol, 42, 192
- Fundytus, 1999, Soc Neurosci Abstracts, 25, 449
- DeLander, 1989, J Pharmacol Exp Ther, 251, 1090
- McCarthy, 1998, Anesth Analg, 86, 830, 10.1213/00000539-199804000-00028 · doi:10.1213/00000539-199804000-00028
- Koyuncuoglu, 1977, Drug Res, 27, 1676
- Kest, 1997, J Pharmacol Exp Ther, 283, 1249
- Wong, 1995, Acta Anaesthesiol Sin, 33, 227
- Gebhardt, 1994, Anaesthesiology, 43, S34
- Abram, 1993, Reg Anesth, 189, 406
- Arendt-Nielsen, 1995, Anesth Analg, 81, 63
- Sethna, 1998, Anesth Analg, 86, 1250, 10.1213/00000539-199806000-00022 · doi:10.1213/00000539-199806000-00022
- Nicolodi, 1998, Int J Clin Pharmacol Res, 18, 93
- Nicolodi, 1997, Int J Clin Pharmacol Res, 17, 97
- Nicolodi, 1995, Int J Clin Pharmacol Res, 15, 181
- Fu, 1997, Anesth Analg, 84, 1086, 10.1213/00000539-199705000-00024 · doi:10.1213/00000539-199705000-00024 · Paper page
- Wong, 1996, Reg Anesth, 21, 534
- Adam, 1999, Anesth Analg, 89, 444, 10.1213/00000539-199908000-00036 · doi:10.1213/00000539-199908000-00036
- Chia, 1998, Anesth Analg, 86, 1245, 10.1213/00000539-199806000-00021 · doi:10.1213/00000539-199806000-00021
- Wilder-Smith, 1998, Anesth Analg, 86, 95
- Tanaka, 1998, Masui, 47, 1109
- Birch, 1995, Pain Rev, 2, 13
- Oye, 1992, J Pharmacol Exp Ther, 260, 1209
- Wu, 1999, Anesth Analg, 88, 1331, 10.1213/00000539-199906000-00025 · doi:10.1213/00000539-199906000-00025
- Henderson, 1999, Anesth Analg, 89, 399, 10.1213/00000539-199908000-00028 · doi:10.1213/00000539-199908000-00028
Cited by
Metabotropic glutamate receptors: novel targets for pain relief
Neugebauer, V. (2001) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.1.2.207 · Cited by 298
Neugebauer, V., Li, W., Bird, G. C., Bhave, G., & Gereau, R. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00052.2003 · Cited by 249
Schaible, H.-G., & Richter, F. (2004) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-004-0468-9 · Cited by 245
Pharmacological characterisation of the spared nerve injury model of neuropathic pain
Erichsen, H. K., & Blackburn-Munro, G. (2002) · Pain · doi:10.1016/s0304-3959(02)00039-8 · Cited by 206
Chiechio, S., Zammataro, M., Morales, M. E., Busceti, C. L., Drago, F., Gereau, R. W., Copani, A., & Nicoletti, F. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054346 · Cited by 190
Metadata
- Authors
- Fundytus, M. E.
- Affiliations
- McGill University (CA)
- Corresponding author
- Fundytus, Marian E.
- Venue
- CNS Drugs
- Published
- 2001
- Volume
- 15
- Issue
- 1
- Pages
- 29-58
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W38310539
- Cited by
- 250
- References
- 513
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 10 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 7 · 2016: 12 · 2015: 13 · 2014: 6 · 2013: 15 · 2012: 13
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- glutamate receptors, nociception, pain processing, NMDA receptor, AMPA receptors, kainate receptors, metabotropic glutamate receptors, opioid tolerance, analgesia, pronociception, antinociception, spinal cord, chronic pain, glutamate release inhibition
- MeSH terms
- Animals, Humans, Models, Biological, Pain, Pain Measurement, Receptors, Glutamate, Excitatory Amino Acid Antagonists, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glutamate Receptors and Nociception: Implications for the Drug Treatment of Pain. https://app.cochat.ai/papers/10.2165/00023210-200115010-00004
- The paper
- Fundytus, M. E. (2001). Glutamate Receptors and Nociception: Implications for the Drug Treatment of Pain. CNS Drugs. https://doi.org/10.2165/00023210-200115010-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.